News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
313,120 Results
Type
Article (30644)
Company Profile (109)
Press Release (282367)
Multimedia
Podcasts (21)
Webinars (3)
Section
Business (82294)
Career Advice (287)
Deals (12664)
Drug Delivery (44)
Drug Development (48332)
Employer Resources (38)
FDA (6686)
Job Trends (6611)
News (148374)
Policy (12135)
Tag
2024 BioCapital Digital (5)
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (3)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (3)
2025 BioForest Digital (1)
2026 Biotech Bay Standard (1)
Academia (2048)
Academic (1)
Accelerated approval (3)
Adcomms (17)
Allergies (18)
Alliances (25224)
ALS (38)
Alzheimer's disease (674)
Antibody-drug conjugate (ADC) (139)
Approvals (6710)
Artificial intelligence (148)
Autoimmune disease (11)
Automation (5)
Bankruptcy (96)
Best Places to Work (5692)
BIOSECURE Act (15)
Biosimilars (46)
Biotechnology (88)
Bladder cancer (71)
Brain cancer (28)
Breast cancer (296)
Cancer (2268)
Cardiovascular disease (64)
Career advice (267)
Career pathing (8)
CAR-T (137)
Cell therapy (313)
Cervical cancer (21)
Clinical research (38359)
Collaboration (505)
Compensation (177)
Complete response letters (10)
COVID-19 (1383)
CRISPR (23)
C-suite (128)
Cystic fibrosis (35)
Data (1251)
Decentralized trials (1)
Denatured (2)
Depression (5)
Diabetes (76)
Diagnostics (4021)
Digital health (4)
Diversity (4)
Diversity, equity & inclusion (13)
Drug discovery (66)
Drug pricing (44)
Drug shortages (4)
Duchenne muscular dystrophy (21)
Earnings (26590)
Editorial (11)
Employer branding (5)
Employer resources (34)
Events (48941)
Executive appointments (327)
FDA (7264)
Featured Employer (16)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (442)
Gene editing (43)
Generative AI (9)
Gene therapy (125)
GLP-1 (250)
Government (1913)
Guidances (19)
Healthcare (9403)
Huntington's disease (4)
IgA nephropathy (4)
Immunology and inflammation (58)
Indications (18)
Infectious disease (1443)
Inflammatory bowel disease (61)
Inflation Reduction Act (4)
Influenza (20)
Intellectual property (42)
Interviews (29)
IPO (6538)
IRA (23)
Job creations (1167)
Job search strategy (249)
Kidney cancer (11)
Labor market (10)
Layoffs (195)
Leadership (2)
Legal (2048)
Liver cancer (77)
Lung cancer (334)
Lymphoma (140)
Machine learning (4)
Management (11)
Manufacturing (120)
MASH (26)
Medical device (3872)
Medtech (3872)
Mergers & acquisitions (6390)
Metabolic disorders (181)
Multiple sclerosis (23)
NASH (5)
Neurodegenerative disease (21)
Neuropsychiatric disorders (5)
Neuroscience (842)
NextGen: Class of 2025 (2740)
Non-profit (2701)
Northern California (1324)
Now hiring (7)
Obesity (81)
Opinion (98)
Ovarian cancer (76)
Pain (29)
Pancreatic cancer (83)
Parkinson's disease (49)
Partnered (11)
Patents (90)
Patient recruitment (62)
Peanut (10)
People (26259)
Pharmaceutical (23)
Pharmacy benefit managers (4)
Phase I (13782)
Phase II (16876)
Phase III (11673)
Pipeline (628)
Policy (71)
Postmarket research (1335)
Preclinical (5981)
Press Release (49)
Prostate cancer (105)
Psychedelics (13)
Radiopharmaceuticals (237)
Rare diseases (158)
Real estate (2068)
Recruiting (15)
Regulatory (9227)
Reports (17)
Research institute (2089)
Resumes & cover letters (21)
RNA editing (3)
RSV (17)
Schizophrenia (20)
Series A (68)
Series B (33)
Service/supplier (2)
Sickle cell disease (31)
Southern California (1061)
Special edition (3)
Spinal muscular atrophy (52)
Sponsored (8)
Startups (1809)
State (1)
Stomach cancer (16)
Supply chain (18)
Tariffs (8)
The Weekly (19)
United States (10880)
Vaccines (346)
Venture capitalists (17)
Weight loss (39)
Women's health (17)
Worklife (4)
Date
Today (83)
Last 7 days (339)
Last 30 days (1271)
Last 365 days (16663)
2025 (4918)
2024 (17962)
2023 (20329)
2022 (26408)
2021 (27618)
2020 (24977)
2019 (20768)
2018 (15477)
2017 (15633)
2016 (15207)
2015 (17557)
2014 (13261)
2013 (10773)
2012 (10996)
2011 (11438)
2010 (10590)
Location
Africa (308)
Alabama (35)
Alaska (4)
Arizona (81)
Arkansas (5)
Asia (20968)
Australia (3996)
California (2856)
Canada (917)
China (342)
Colorado (140)
Connecticut (138)
Delaware (93)
Europe (46884)
Florida (422)
Georgia (76)
Idaho (20)
Illinois (250)
India (16)
Indiana (137)
Iowa (5)
Japan (87)
Kansas (36)
Kentucky (18)
Louisiana (1)
Maine (13)
Maryland (393)
Massachusetts (2126)
Michigan (50)
Minnesota (138)
Missouri (46)
Montana (14)
Nebraska (9)
Nevada (9)
New Hampshire (39)
New Jersey (972)
New Mexico (11)
New York (955)
North Carolina (353)
North Dakota (4)
Northern California (1324)
Ohio (85)
Oklahoma (6)
Oregon (13)
Pennsylvania (514)
Puerto Rico (4)
Rhode Island (13)
South America (399)
South Carolina (6)
Southern California (1061)
Tennessee (28)
Texas (564)
Utah (70)
Virginia (58)
Washington D.C. (41)
Washington State (347)
West Virginia (2)
Wisconsin (36)
313,120 Results for "netherlands cancer institute nci".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
LIXTE Biotechnology Holdings to Collaborate with Roche and Netherlands Cancer Institute in New Colon Cancer Clinical Trial
LIXTE Biotechnology Holdings, Inc., a clinical stage pharmaceutical company, announced a collaboration with Roche and the Netherlands Cancer Institute to conduct a new clinical trial in immune therapy unresponsive metastatic colon cancer.
June 14, 2024
·
4 min read
Press Releases
ORYZON Announces First Patient Dosed in NCI-Sponsored Phase I/II Clinical Trial of Iadademstat Plus Immune Checkpoint Inhibitors in 1L Extensive Stage Small Cell Lung Cancer
April 15, 2025
·
7 min read
Press Releases
ATCC Announces Award from NCI to Support Research and Vaccine Development for Cancer and HIV
January 9, 2025
·
2 min read
Press Releases
Veracyte Announces Decipher Prostate Genomic Classifier Results are Linked to Real-World Data in National Cancer Institute’s SEER Specialized Database Release
April 21, 2025
·
4 min read
Press Releases
SciTech Development, Inc. Announces Receipt of Drug Supply From The National Cancer Institute (NCI)
September 18, 2024
·
2 min read
Press Releases
NCI-Sponsored Study Shows Positive Data for Lucid Diagnostics’ EsoGuard® Esophageal DNA Test in Patients Without Symptomatic GERD
April 25, 2025
·
4 min read
Business
LIXTE, Netherlands Cancer Institute, and Oncode Institute to Expand Collaboration
LIXTE Biotechnology Holdings, Inc. announced that it has signed an agreement to expand its collaboration with the Netherlands Cancer Institute and Oncode Institute to study drug synergies of LIXTE’s lead clinical compound, LB-100, with immunotherapy in various cancers.
October 16, 2023
·
5 min read
Press Releases
Sumitomo Pharma America enters into a Cooperative Research and Development Agreement with the National Cancer Institute to Advance Clinical Understanding of Enzomenib
April 14, 2025
·
5 min read
Press Releases
Biosplice Therapeutics Announces Initiation of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) Trial Sponsored by the National Cancer Institute (NCI)
September 12, 2024
·
4 min read
Business
BlueSphere Bio Establishes Strategic Collaboration with the National Cancer Institute to Advance Treatments for Rare Respiratory Disease
BlueSphere Bio, a T-cell receptor (TCR) T-cell therapy company utilizing a powerful TCR discovery platform to identify novel therapeutic candidates for patients with hematologic malignancies and solid tumors, today announced a strategic collaboration with the National Cancer Institute (NCI), part of the National Institutes of Health.
June 4, 2024
·
5 min read
1 of 31,312
Next
